Authors:
Avinash Singh, Amit Patil
Download free PDF
Muscle Strengthening Devices Market Size & Share 2026-2035
Report ID: GMI12749
|
Published Date: October 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Muscle Strengthening Devices Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
Muscle Strengthening Devices Market Size
The global muscle strengthening devices market was valued at USD 6.63 billion in 2025, is projected to reach USD 7.04 billion in 2026, and is expected to grow at a 6.1% CAGR (2026–2035) to reach USD 12.04 billion by 2035.
Muscle Strengthening Devices Market Key Takeaways
Market Leader: Technogym S.p.A. led with over 8.6% market share in 2025.
Leading Players: Top 5 players in this market include Technogym S.p.A., Life Fitness (KPS Capital Partners), Matrix Fitness (Johnson Health Tech), OMRON Corporation, BTL Industries Ltd., which collectively held a market share of 30.2% in 2025.
The market is moving beyond a conventional gym-equipment cycle toward a broader demand base spanning preventive fitness, musculoskeletal rehabilitation, and performance training. Premiumization is increasingly tied to connected functionality, adaptive programming, clinical usability, and service support, while established mechanical equipment retains an important installed-base and replacement-market role.
GMI Analyst View
Based on input from industry leaders and our primary engagement with market participants, the global muscle strengthening devices market registered USD 6.27 billion in revenue during the year preceding the base period. We see this as evidence of a demand base that is becoming more closely tied to long-term health, mobility, and recovery priorities rather than solely discretionary fitness spending. The convergence of adaptive resistance, electrical stimulation, and real-time performance feedback is shifting product-development priorities for both established equipment manufacturers and digitally oriented entrants.
Muscle Strengthening Devices Market Trends, Growth Drivers & GMI Forecast Outlook
Demand is being shaped by physical inactivity, population aging, and the movement of digital training capabilities into both consumer and clinical settings. Growth will depend on suppliers translating product innovation into credible outcomes, accessible pricing, and compliant market access across increasingly differentiated fitness and rehabilitation channels.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Physical inactivity gives equipment providers a route into wellness programs, rehabilitation protocols, and consumer training routines rather than a single discretionary retail category. Suppliers that can support progression tracking, safe use, and sustained engagement are better positioned to capture repeat use, particularly where employers, providers, or fitness operators seek tools that connect activity goals with measurable adherence.
Population aging strengthens the clinical rationale for preserving mobility and muscle function. This shifts purchasing criteria toward evidence, usability, clinician confidence, and compatibility with supervised or home-based care. It also expands the value of products that can operate across rehabilitation and general conditioning contexts without compromising safety or patient suitability.
Connected platforms are changing how value is created after the initial equipment sale. Personalized load adjustment, program libraries, and performance analytics can deepen user engagement and give manufacturers a more durable relationship with facilities and consumers. The commercial opportunity is strongest where digital features solve a practical training or rehabilitation problem rather than function as a standalone software overlay.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
The main affordability challenge sits at the boundary between clinical-grade products and consumer wellness equipment. Higher-specification systems often require product training, service support, validated protocols, and professional oversight, all of which raise the delivered cost. Where reimbursement is uncertain, buyers may defer adoption even when the underlying clinical or performance need is clear.
Regulatory scrutiny is especially consequential for electrically powered devices marketed through direct-to-consumer and cross-border channels. Suppliers must align labeling, claims, product documentation, and post-market controls with the requirements of each market. Those obligations can narrow the addressable channel for lightly regulated entrants while reinforcing the position of manufacturers that have incorporated compliance into product design and distributor management.
Regulatory fragmentation also complicates global launch planning. A device that is commercially viable in one jurisdiction may require a different evidence package, clearance route, or local representative elsewhere. This can create a material timing advantage for companies that can coordinate product development, clinical substantiation, and regulatory strategy before committing to broader channel expansion.
GMI Analyst View
We believe the market's most durable opportunity lies in the overlap between clinical need and consumer expectations for convenient, personalized training. Products that can establish credible outcomes while remaining intuitive for unsupervised or semi-supervised use should be better insulated from purely discretionary spending swings. The strategic challenge for suppliers is to turn connectivity into adherence and service value, rather than simply adding digital features to existing hardware.
Muscle Strengthening Devices Market Segment Analysis
By Device Type
Resistance training equipment generated USD 4.11 billion in 2025 and is projected to account for a 59.0% share of the global muscle strengthening devices market by 2035. Its installed base across commercial gyms, institutional facilities, and home settings gives the category broad replacement demand, while smart load monitoring and guided resistance features are extending the relevance of established mechanical formats.
Vibration therapy devices held an 11.0% share in 2025 and are projected to reach USD 1.20 billion by 2035. The category retains a specialized role in physiotherapy, sports recovery, and premium fitness settings, where neuromuscular activation and recovery use cases support adoption. Its position is increasingly shaped by how effectively vendors differentiate targeted therapeutic applications from broader connected resistance offerings.
Other device types are projected to generate USD 0.97 billion by 2035 and held an 8.0% share in 2025. Blood flow restriction systems, pneumatic resistance equipment, and related accessories address use cases where conventional loading is unsuitable or where precise control of training intensity is required. Their opportunity is closely tied to clinician and performance-specialist endorsement.
By Application
Muscle strengthening & conditioning generated USD 2.12 billion in 2025 and is expected to account for a 30.0% share by 2035. This remains the core demand pool for commercial fitness operators, home users, and workplace wellness programs, although the mix is gradually broadening as clinical and specialized performance applications gain importance.
Rehabilitation & recovery generated USD 1.46 billion in 2025 and is projected to reach USD 2.77 billion by 2035. Institutional demand is supported by the growing use of non-pharmacological musculoskeletal interventions and structured recovery protocols. Vendors with clinical evidence, regulatory readiness, and therapist-facing support are better placed to access this purchasing pathway.
Sports performance enhancement held a 17.0% share in 2025 and is projected to reach USD 2.05 billion by 2035. Professional teams, training centers, and sports science organizations require equipment that combines repeatable performance outcomes with portability and durability. These buyers also function as influential reference customers for suppliers seeking visibility in adjacent premium fitness segments.
Injury prevention generated USD 0.80 billion in 2025 and is forecast to expand at a 7.0% CAGR (2026–2035). Demand is increasingly connected to prehabilitation, occupational health, and sports medicine programs that seek to improve conditioning before injury occurs. Adoption depends on whether device providers can align their products with practitioner workflows and risk-management priorities.
Body toning & fat loss is projected to reach USD 1.08 billion by 2035 and held a 9.0% share in 2025. Purchasing behavior in this application is strongly influenced by perceived outcomes, brand credibility, and the quality of customer education. Suppliers face a clear need to distinguish regulated or clinically substantiated offerings from lower-cost products built around lifestyle-oriented claims.
Posture correction is projected to reach USD 0.60 billion by 2035 and accounted for a 5.0% share in 2025. Sedentary work patterns and greater attention to musculoskeletal wellness are widening the application's relevance. Product design must balance ease of use with programs that support sustained behavior change rather than short-term corrective use.
By End-User
Fitness enthusiasts generated USD 2.65 billion in 2025 and are projected to account for a 38.0% share by 2035. This customer group continues to support broad demand for resistance equipment, connected platforms, and consumer EMS products. Retention will increasingly depend on product ecosystems that make training progression visible and reduce friction in home or gym use.
Athletes & sports professionals held a 20.0% share in 2025 and are projected to reach USD 2.53 billion by 2035. These users prioritize performance reliability, clinical credibility, and deployment flexibility across training and recovery environments. Their procurement decisions can carry outsized signaling value for manufacturers targeting commercial facilities and high-performance consumer segments.
Rehabilitation patients generated USD 1.46 billion in 2025 and are forecast to grow at a 6.6% CAGR (2026–2035). Physician recommendation, therapist confidence, and reimbursement eligibility shape demand more directly than consumer marketing. Suppliers seeking access to this segment need to demonstrate that their products can integrate into clinical care plans and monitored recovery routines.
The elderly & geriatric population is projected to reach USD 1.57 billion by 2035 and is expected to grow at a 7.0% CAGR (2026–2035). Devices for this group require simplified controls, safety-oriented design, and compatibility with lower-intensity exercise or care settings. Products that preserve independence while allowing professional oversight are likely to have the strongest fit.
By Distribution Channel
Online channels generated USD 2.32 billion in 2025 and are projected to capture a 42.0% share by 2035. Digital commerce is particularly effective for products that can be researched, compared, and used without complex installation or clinician intervention. Brand-owned channels can add value through training content, subscriptions, and direct customer relationships.
Offline channels generated USD 4.31 billion in 2025 and are projected to reach USD 6.98 billion by 2035. Physical distribution remains essential for commercial-grade, medical, and high-consideration purchases that involve demonstrations, site planning, installation, or clinical documentation. The channel's resilience is rooted in service intensity rather than simple transactional access.
GMI Analyst View
We see a widening divide between equipment categories that compete mainly on unit price and those that compete on evidence, personalization, and service capability. Clinical rehabilitation is particularly attractive because it rewards validated outcomes and creates purchasing relationships that are less dependent on promotional intensity. Manufacturers that can serve both professional and consumer environments without diluting their credibility should have greater strategic flexibility.
Muscle Strengthening Devices Market Regional Analysis
North America Muscle Strengthening Devices Market Analysis
The global muscle strengthening devices market in North America generated USD 2.65 billion in 2025 and is projected to reach USD 4.45 billion by 2035. The region combines mature commercial fitness infrastructure with established rehabilitation and sports medicine channels, creating a demand environment that supports both high-volume equipment replacement and premium clinical technology adoption.
U.S.
The U.S. held a 90.0% share of North American revenue in 2025 and is projected to generate USD 4.01 billion by 2035. Its market is supported by deep commercial-fitness penetration, broad clinical procurement pathways, and strong consumer spending on connected training. FDA clearance also serves as an important credibility marker for suppliers looking to extend their reach into institutional and international channels.
Canada
Canada generated USD 270 million in 2025 and is forecast to expand at a 5.0% CAGR (2026–2035). Provincial rehabilitation investment, urban fitness demand, and integration with North American distribution networks support adoption. Buyers continue to value equipment providers that can combine commercial service coverage with clinical documentation and product support.
Europe Muscle Strengthening Devices Market Analysis
Europe held a 26.0% share of the market in 2025 and is projected to reach USD 2.89 billion by 2035. Demand is supported by established physiotherapy networks, high-income fitness consumers, and active-aging initiatives. At the same time, regulatory expectations create a competitive advantage for manufacturers with strong clinical-affairs and post-market capabilities.
Germany
Germany generated USD 340 million in 2025 and is projected to account for a 20.0% share of European revenue by 2035. Commercial clubs, physiotherapy practices, and technically informed consumers support demand for connected resistance and EMS solutions. The country's manufacturing base also provides a favorable environment for suppliers serving both domestic and export markets.
UK
The UK held an 18.0% share of European revenue in 2025 and is projected to reach USD 520 million by 2035. Medical-device market access requirements add complexity for suppliers, while commercial gym operators and premium fitness facilities continue to invest in differentiated strength and recovery equipment. The market favors vendors able to combine regulatory readiness with reliable local channel support.
France
France generated USD 260 million in 2025 and is expected to grow at a 5.1% CAGR (2026–2035). EMS studio formats and a developed physiotherapy ecosystem support demand across consumer and professional settings. Product adoption is strongest where suppliers can demonstrate practical use protocols and position devices clearly within local health and fitness channels.
Italy
Italy held a 12.0% share of European revenue in 2025 and is projected to generate USD 350 million by 2035. Domestic strength in premium fitness equipment manufacturing, combined with a strong sports culture and growing rehabilitation demand, supports the market. Italian vendors also benefit from the opportunity to translate local product credibility into export-oriented commercial relationships.
Spain
Spain generated USD 190 million in 2025 and is projected to account for an 11.0% share of European revenue by 2035. Investment in commercial fitness capacity and sports-science applications is expanding the customer base for performance-oriented equipment. Demand is reinforced by urban consumers seeking connected and professionally guided training formats.
Asia Pacific Muscle Strengthening Devices Market Analysis
Asia Pacific held a 23.0% share of the market in 2025 and is forecast to grow at a 7.8% CAGR (2026–2035). The region combines expanding gym infrastructure, large addressable populations, rising health awareness, and an increasingly capable device-manufacturing base. Growth will vary by country according to consumer purchasing power, clinical reimbursement, and the maturity of local fitness ecosystems.
China
China generated USD 610 million in 2025 and is projected to reach USD 1.36 billion by 2035. Commercial fitness expansion and increasing consumer expenditure on health are enlarging the demand base, while domestic manufacturers are advancing from contract production toward proprietary connected platforms. The market's scale creates significant opportunity, but also sharpens competition across price tiers.
Japan
Japan held an 18.0% share of Asia Pacific revenue in 2025 and is projected to reach USD 520 million by 2035. Clinical rehabilitation and healthy-aging demand are particularly important to the country's market structure. Suppliers that can demonstrate suitability for supervised recovery and mobility-preservation programs are well positioned within institutional channels.
India
India is projected to reach USD 590 million by 2035 and is forecast to grow at a 9.4% CAGR (2026–2035). Urbanization, gym expansion, and rising sports participation are widening consumer demand, while clinical-device penetration remains comparatively early stage. The long-term opportunity depends on improving access to rehabilitation infrastructure and developing price points that fit a diverse consumer base.
South Korea
South Korea generated USD 170 million in 2025 and is projected to account for an 11.1% share of Asia Pacific revenue by 2035. A sophisticated fitness culture and domestic electronics and device capabilities support demand for differentiated EMS and connected products. Corporate wellness and elite sports applications provide additional routes to premium equipment adoption.
Australia
Australia held a 7.0% share of Asia Pacific revenue in 2025 and is projected to reach USD 200 million by 2035. Strong participation in sport and fitness, coupled with a developed sports medicine ecosystem, supports demand for premium training and recovery technologies. Urban professional consumers remain an important source of discretionary equipment spending.
Latin America Muscle Strengthening Devices Market Analysis
Latin America generated USD 400 million in 2025 and is forecast to grow at a 6.9% CAGR (2026–2035). Commercial gym expansion, urban health and fitness participation, and developing rehabilitation awareness underpin demand. The region remains sensitive to macroeconomic conditions and import costs, increasing the importance of localized distribution and appropriately tiered product portfolios.
Brazil
Brazil held a 45.0% share of Latin American revenue in 2025 and is projected to reach USD 340 million by 2035. Its large commercial-fitness sector supports ongoing demand for resistance equipment, while sports medicine and physiotherapy create an additional clinical market. Local assembly and manufacturing can be strategically important in managing cost sensitivity and import exposure.
Mexico
Mexico generated USD 100 million in 2025 and is forecast to grow at a 7.2% CAGR (2026–2035). Proximity to U.S. equipment trends, expanding urban fitness infrastructure, and increasing professional sports investment are strengthening demand. Suppliers with efficient cross-border logistics and accessible service models have a meaningful route to market.
Argentina
Argentina held a 12.0% share of Latin American revenue in 2025 and is projected to generate USD 90 million by 2035. The market combines a relatively sophisticated fitness and sports medicine culture with substantial macroeconomic and import-related constraints. Demand for premium equipment is therefore closely tied to periods of greater purchasing stability and channel confidence.
Middle East & Africa Muscle Strengthening Devices Market Analysis
Middle East & Africa generated USD 330 million in 2025 and is projected to reach USD 660 million by 2035. Government-backed wellness initiatives, investment in premium sports infrastructure, and demand for rehabilitation services are broadening the region's market base. Channel development and access to trained service providers will remain central to converting policy-led investment into sustained equipment utilization.
UAE
The UAE held a 22.0% share of Middle East & Africa revenue in 2025 and is projected to grow at a 7.9% CAGR (2026–2035). Premium studios, hospitality facilities, and sports-performance centers create concentrated demand for high-specification equipment. The country's role as a regional commercial hub also strengthens its importance for distributor-led market access across the Gulf.
Saudi Arabia
Saudi Arabia generated USD 90 million in 2025 and is projected to account for a 28.8% share of Middle East & Africa revenue by 2035. Investment in fitness infrastructure and physical activity participation is expanding both commercial and institutional demand. The market is increasingly attractive to suppliers that can support large-scale facility development while adapting product and service models to local channel conditions.
South Africa
South Africa held an 18.0% share of Middle East & Africa revenue in 2025 and is forecast to grow at a 6.2% CAGR (2026–2035). Its established urban fitness, professional sports, and private physiotherapy sectors make it an important entry point for suppliers serving sub-Saharan Africa. Reliable service coverage and pricing discipline are critical in converting that positioning into sustainable growth.
GMI Analyst View
We expect regional performance to be determined less by broad consumer interest alone than by the depth of local clinical, service, and distribution infrastructure. North America retains a strong foundation in institutional purchasing, while Asia Pacific offers the most compelling mix of expanding participation and manufacturing capability. In the Middle East, policy-backed facility investment can accelerate adoption, but long-term success will depend on utilization, operator capability, and local after-sales support.
Muscle Strengthening Devices Market Share & Competitive Landscape
The global muscle strengthening devices market share is distributed across a broad group of equipment manufacturers, clinical-device providers, and specialized technology companies. The top five players collectively held a 30.2% share in 2025, indicating a market in which scale and brand recognition matter, but where category specialization, regulatory capability, and local channel execution continue to create room for differentiated competitors.
Technogym S.p.A. held an 8.6% share in 2025. Its position is reinforced by a broad commercial equipment portfolio and a digital ecosystem that connects adaptive resistance, coaching, and performance analytics. The company's Healthness strategy and Biostrength platform reflect an effort to position connected strength training around personalized health outcomes as well as traditional fitness use cases [3].
Life Fitness (KPS Capital Partners) held a 7.3% share in 2025. The company's strength-equipment position is supported by its Hammer Strength portfolio and its established relationships with commercial gyms, hospitality venues, and professional training facilities. Its competitive relevance lies in equipment breadth, facility-oriented service capability, and an installed base that supports replacement and upgrade demand.
Matrix Fitness (Johnson Health Tech) held a 5.9% share in 2025. Matrix competes across commercial fitness environments through a portfolio spanning strength and cardio equipment, with particular access to gyms, hotels, and corporate wellness facilities. Its ability to serve multi-site operators and premium hospitality customers supports a differentiated channel position.
OMRON Corporation is a material participant in the EMS/NMES category, where its healthcare distribution reach and medical-device credibility can support both clinical and consumer-facing applications. Its advantage is strongest in markets where classification, reimbursement, and clinical channel access influence procurement decisions.
BTL Industries Ltd. competes at the intersection of clinical aesthetics, rehabilitation, and high-intensity electromagnetic technology. FDA clearance for Emsculpt Neo covering rehabilitative indications expands the company's ability to address hospital and outpatient procurement opportunities beyond its established aesthetic positioning [4].
Zynex Medical Inc. addresses prescription electrotherapy and NMES demand through its multi-modality device portfolio. Its focus on reimbursed clinical channels and federal healthcare access strengthens its relevance in institutional markets where documentation, payer alignment, and provider relationships influence purchasing decisions [7].
Other competitors, including Beurer GmbH, Hyperice Inc., Power Plate, Keiser Corporation, Compex, and PowerDot, compete through targeted positions in consumer EMS, vibration recovery, pneumatic resistance, and sports-performance applications. Competitive intensity is increasingly determined by the ability to combine credible device performance with channel-specific support, digital engagement, and regulatory readiness.
Recent Industry Developments
BTL Industries Ltd. secures FDA clearance for Emsculpt Neo rehabilitative indications. BTL announced FDA clearance for Emsculpt Neo for neuromuscular tissue stimulation in rehabilitative use cases, broadening the platform's potential application across post-surgical recovery, muscle re-education, and outpatient rehabilitation settings [4].
Technogym launches Healthness and Biostrength AI adaptive platform. Technogym introduced its Healthness strategy and expanded its adaptive resistance proposition through Biostrength, integrating individualized load, range-of-motion, posture, and recovery guidance into its connected training ecosystem [3].
Zynex Medical and MellingMedical announce federal healthcare partnership. The partnership expands the distribution route for Zynex electrotherapy and rehabilitation devices across U.S. federal healthcare settings, strengthening the company's access to institutional purchasers focused on non-invasive pain management and rehabilitation [7].
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →